CVS Caremark (NYSE:CVS) hit a new 52-week high Thursday as it is currently trading at $49.59, above its previous 52-week high of $49.23 with 2.4 million shares traded as of 9:35 a.m. ET. Average volume has been 6.3 million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- CVS Caremark (NYSE: CVS) hit a new 52-week high Thursday as it is currently trading at $49.59, above its previous 52-week high of $49.23 with 2.4 million shares traded as of 9:35 a.m. ET. Average volume has been 6.3 million shares over the past 30 days. CVS Caremark has a market cap of $59.28 billion and is part of the services sector and retail industry. Shares are up 16.6% year to date as of the close of trading on Wednesday. CVS Caremark Corporation provides pharmacy health care services in the United States. The company has a P/E ratio of 16, below the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates CVS Caremark as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full CVS Caremark Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.